Penumbra
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.About PEN
Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system.
CEOAdam Elsesser
CEOAdam Elsesser
Employees4,700
Employees4,700
HeadquartersAlameda, California
HeadquartersAlameda, California
Founded2004
Founded2004
Employees4,700
Employees4,700
PEN Key Statistics
Market cap13.19B
Market cap13.19B
Price-Earnings ratio74.08
Price-Earnings ratio74.08
Dividend yield—
Dividend yield—
Average volume662.11K
Average volume662.11K
High today$337.00
High today$337.00
Low today$334.90
Low today$334.90
Open price$337.00
Open price$337.00
Volume338.87K
Volume338.87K
52 Week high$362.41
52 Week high$362.41
52 Week low$221.26
52 Week low$221.26
Stock Snapshot
Penumbra(PEN) stock is priced at $336.18, giving the company a market capitalization of 13.19B. It carries a P/E multiple of 74.08.
On 2026-03-14, Penumbra(PEN) stock traded between a low of $334.90 and a high of $337.00. Shares are currently priced at $336.18, which is +0.4% above the low and -0.2% below the high.
The Penumbra(PEN)'s current trading volume is 338.87K, compared to an average daily volume of 662.11K.
In the last year, Penumbra(PEN) shares hit a 52-week high of $362.41 and a 52-week low of $221.26.
In the last year, Penumbra(PEN) shares hit a 52-week high of $362.41 and a 52-week low of $221.26.
Analyst ratings
74%
of 19 ratingsBuy
21.1%
Hold
73.7%
Sell
5.3%
People also own
Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.